Optimi Health Corp.
Optimi Health Corp. functions as an end-to-end GMP manufacturer and supplier of psychedelic substances. It offers formulation, active pharmaceutical ingredients (APIs), and drug product manufacturing from preclinical stages to analysis and commercial distribution and It also offers botanical psilocybin and MDMA. The company was founded on May 27, 2020 and is headquartered in Squamish, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.49 | $99,500 | -$344,647 |
| 2025 Q1 | -0.48 | $0 | -$639,896 |
| 2025 Q4 | -0.42 | -$64,029 | -$1M |
| 2025 Q3 | -0.28 | $196,389 | -$858,471 |
| 2025 Q2 | -0.06 | $61,241 | -$76,284 |
| 2024 Q1 | -0.42 | $232,700 | -$330,662 |
| 2024 Q4 |
| -0.56 |
| $57,859 |
| -$793,183 |
| 2024 Q3 | -0.55 | $124,027 | -$1M |